Such a policy would remove significant risk from the sale of CBD products. Global scientists, business minds and thought leaders have come together to form CBD Living, an international, world-class company producing over 100 CBD products far superior to any other hemp-derived CBD product on the market. In February 2020, the UK FSA advised vulnerable people, such as pregnant women, breastfeeding mothers, and those already taking medication for other medical concerns not to take CBD. The FSA further recommended that healthy adults should not consume more than 70 mg CBD per day. In September 2018, following its approval by the FDA for rare types of childhood epilepsy, Epidiolex was rescheduled as a Schedule V drug to allow for its prescription use.